Primer on the U.S. Pharmaceuticals Sector: Foundation for Analysis
The Pharmaceuticals sector (GICS 352020) remains a cornerstone of the global health economy and a significant component of equity indices. This primer delivers a comprehensive analysis of the sector’s structure and key drivers. It dissects the pharmaceutical value chain, from high-risk R&D characterized by significant attrition, to complex manufacturing and the convoluted U.S. pricing ecosystem….